Escherichia coli haemolysin A (HlyA), an RTX toxin, is secreted probably as an unfolded intermediate, by the type I (ABC transporter-dependent) pathway, utilizing a C-terminal secretion signal. However, the mechanism of translocation and post-translocation folding is not understood. We identified a mutation (hlyA99) at the extreme C terminus, which is dominant in competition experiments, blocking secretion of the wild-type toxin co-expressed in the same cell. This suggests that unlike recessive mutations which affect recognition of the translocation machinery, the hlyA99 mutation interferes with some later step in secretion. Indeed, the mutation reduced haemolytic activity of the toxin and the activity of b-lactamase when the latter was fused to a Cterminal 23 kDa fragment of HlyA carrying the hlyA99 mutation. A second mutant (hlyAdel6), lacking the six C-terminal residues of HlyA, also showed reduced haemolytic activity and neither mutant protein regained normal haemolytic activity in in vitro unfolding/refolding experiments. Tryptophan fluorescence spectroscopy indicated differences in structure between the secreted forms of wild-type HlyA and the HlyA Del6 mutant. These results suggested that the mutations affected the correct folding of both HlyA and the b-lactamase fusion. Thus, we propose a dual function for the HlyA C terminus involving an important role in post-translocation folding as well as targeting HlyA for secretion.
INTRODUCTION
Bacteria have developed a wide range of defence strategies to survive in hostile and competitive environments. Some of these strategies rely on the secretion of toxins that have various effects, including disruption of host membranes. The secretion of proteins by Gram-negative bacteria involves an extraordinarily wide variety of distinct mechanisms. The 107 kDa toxin haemolysin A (HlyA; a member of the RTX protein family) produced by invasive Escherichia coli strains, in particular in uropathogenic E. coli, is secreted via the type I (ABC) system ) (see Supplementary Fig. S1 , available with the online version of this paper).
HlyA secretion (for recent reviews see Delepelaire, 2004; Holland et al., 2005) is accomplished via a trans-envelope conduit or tunnel assembled in response to the presence of nascent HlyA (Balakrishnan et al., 2001) . This tunnel connects the cytoplasm of E. coli directly to the external surface and is composed of three proteins: HlyB, an ABC transporter, TolC, an outer-membrane protein with an extensive helical domain extending into the periplasm (Koronakis et al., 2000) , and HlyD, a so-called membrane fusion protein, which likely bridges HlyB and TolC to complete the tunnel. Secretion is initiated by the docking of the C-terminal secretion signal of HlyA to the HlyBD complex, which appears to involve direct interaction between the secretion signal and HlyB in competition with ATP (Benabdelhak et al., 2003) . HlyA is then transported directly to the cell surface through the HlyB : HlyD : TolC trans-envelope tunnel, where the restricted diameter of TolC (Andersen et al., 2002) indicates that HlyA must be translocated as an unfolded polypeptide chain. Previous evidence suggests that HlyA molecules can then proceed to the external medium by two distinct mechanisms: directly to the medium as the free protein or following accumulation in a trypsin-accessible form on the cell surface (Pimenta et al., 2005) with a final release step in association with outer membrane vesicles (Balsalobre et al., 2006) .
In type I secretion systems, the unprocessed targeting sequence, which is necessary and sufficient for secretion, is located at the C terminus of the protein. For HlyA, this has been subjected to extensive mutation and deletion studies and the targeting sequence has been shown to consist of a stretch of 50-60 aa at the extreme C terminus of the protein . However, the targeting signal sequence is apparently not strongly conserved in either HlyA or other type I proteins. Nevertheless, while many individual residues can be substituted with little effect, some residues and some putative structural motifs distributed throughout the targeting sequence are required for full secretion activity. In particular, at least seven residues dispersed between positions 215 and 246 reduced secretion levels by 50 % or more when substituted. Moreover, the effects of these mutations were additive. Although overall the signal sequences for type I substrates are highly variable, some conservation at the extreme terminus is apparent when subfamilies of RTX proteins are compared. Thus, the last five C-terminal residues appear to constitute a relatively well-conserved motif in the haemolysin and leukotoxin subfamily which clearly differs, for example, from the C terminus of the RTX proteases (Holland et al., 2003) . This suggests that the extreme terminus may confer specificity on the secretion process at some level.
Calcium ions, bound to each RTX repeat, are required for the haemolytic activity of RTX proteins such as HlyA , with calcium ions seemingly triggering refolding of the RTX proteins, either while they are still bound to the cell envelope or after release to the extracellular space. It is also assumed that intracellular refolding of RTX proteins is prevented due to the low cytosolic Ca 2+ concentration (300 nM), despite extracellular Ca 2+ concentrations of up to 10 mM (Jones et al., 2002) . Sanchez-Magraner et al. (2007) demonstrated that in the presence of Ca 2+ , the b-roll structure of the RTX domain of HlyA is compacted and stabilized, and Chenal et al. (2009) recently described similar effects of Ca 2+ on the otherwise disordered RTX domain of the adenylate cyclase toxin. These results and a further study (Herlax & Bakas, 2007) appear to point towards HlyA being a conformationally flexible molecule, whose properties are commensurate with secretion in a relatively unfolded state on the one hand and the requirement for radical conformational changes for insertion into membranes on the other. For HlyA or for other bacterial proteins secreted (in a presumably unfolded form) directly to the exterior, the mechanism of final folding on the cell surface remains an intriguing puzzle, with extracellular calcium playing an important role.
In a previous study, we identified a fusion protein, CIZHlyA (containing most of the LacZ protein), which blocked the Hly translocator. This enabled us to develop a secretion competition system involving co-expression of wild-type HlyA and the fusion protein to analyse the role of some important residues between positions 246 and 215 that affected secretion. Such mutations, when incorporated into the C-terminus of the fusion, were shown to be recessive, suggesting that the affected amino acids are involved in an early step of translocation, probably the recognition of the translocator (Holland et al., 2003) . Importantly, this system, in contrast with competition for secretion between wild-type and mutant HlyA, easily distinguishes the two forms of HlyA and gives an essentially null end point, unless secretion inhibition by the fusion is alleviated by a particular mutation. Here, we describe a mutant, hlyA99, which carries four substitutions in the last six residues of HlyA ( Supplementary Fig. S2 ). This mutation displayed a dominant phenotype, since, when present in the CIZ-HlyA fusion, secretion of the wild-type HlyA is inhibited, indicating a defect in a later step in the translocation pathway. In fact, further studies described in this report indicate that the hlyA99 mutation and another mutation, which removes the six C-terminal residues of HlyA (hlyAdel6), appear primarily to affect the folding and therefore the activity of the toxin, suggesting a novel role for the extreme C-terminal residues of HlyA.
METHODS
Bacterial strains and growth conditions. The E. coli strain NM522 [D(lac-proAB) thi-1 supE hsdR17 (r k 2 m k 2 ), (F9, proAB, lacI q , ZDM15)] was used for expression and secretion of HlyA and blac23kDaHlyA. Cells were grown in Luria broth (LB) at 37 uC or at 30 uC for competition experiments in order to limit expression from the thermo-inducible l promoter (see below). CaCl 2 (10 mM) was added to LB when cultures were to be assayed for HlyA toxin activity. For translocation kinetics, SE5000 expressing hlyCA (pLG813) and hlyBD (pLG814) was grown in M63 minimal medium plus 1 mM CaCl 2 at 37 uC. E. coli BL21(DE3) {ompT gal dcm lon hsdSB(r B 2 m B 2 ) l[DE3 (lacI lacUV5-T7 gene 1 ind1 sam7 nin5)]} was used for production of wild-type pro-HlyA (pSU2726) and pro-HlyA Del6 (pSU2726 del6) as inclusion bodies (IBs). Cultures were grown at 37 uC in 26YT broth (tryptone 16 g l 21 , yeast extract 10 g l 21 , NaCl, 5 g l 21 ) and cells were harvested 3 h after induction. Strain CJ236 [dut, ung, thi-1 relA:pCJ105(Cm r )] was used in order to produce uracil-rich single strand phage DNA for oligonucleotide mutagenesis. This strain was grown as indicated by the manufacturer (Bio-Rad). When required, antibiotics were supplied at a final concentration of 25 mg kanamycin ml 21 , 25 mg chloramphenicol ml 21 , 100 mg ampicillin ml 21 , 10 mg tetracycline ml 21 . IPTG (0.5 mM) was added to the culture to induce expression of hybrid proteins under the control of lac promoters.
Deletion of the terminal 18 nt of hlyA to generate hlyAdel6. The hlyAdel6 mutation was constructed using PCR with pLG813 as template DNA and the following oligonucleotides: H3, 59-GAGCTCAAATGCCAACAATAACC-39, hybridizing to the 59 end of hlyA; and KR1, 59-AAATTAATAAATTATATTGAGTTCCG-39, hybridizing to hlyA codons 1015-1018 (underlined) and to 39 noncoding sequence (stop codon is depicted in bold) thereby deletzing amino acid codons 1019-1024 (inclusive) but leaving the termination codon intact. Note that the four 59 nt of KR1 correspond to half of a blunt SwaI restriction site. The 3.1 kb PCR product was digested with HindIII and the 2.4 kb fragment cloned into HindIII/SwaI-digested pLG813. The hlyAdel6 mutation was confirmed by sequencing. HlyA Del6 was constructed using ligase chain reaction and the following oligonucleotides: HlyAdelstop_for 59-TATGGACGGAACTCAATAT-AATTGACAG-39, and HlyAdelstop_rev 59-TGCTGATGCTGTCA-ATTATATTGAGTTC-39, which introduce a stop codon (bold) in pSU2726. Introduction of the stop codon was confirmed by sequencing.
Transfer of signal mutations into genes encoding blac23kDaHlyA and CIZ-HlyA. The point mutations F989P and (D55) in the HlyA secretion signal were transferred from plasmid pLG816 containing these mutations into pLG811, which carryies the CIZHlyA fusion (LacZ fused N-terminally to the 81 kDa C-terminal domain of HlyA), by in vitro recombination using the BglII and NcoI unique restriction sites present in both plasmids and localized at 286 and 2850 bp from the 39 end of hlyA, respectively. In the case of the hlyA99 mutation, the SalI and NcoI sites were used to transfer the DNA fragment from pLG813-hlyA99 into pLG811. Transfer of hlyA99 into the gene encoding blac-23kDaHlyA was achieved by ligation of the 0.25 kb BglII/SmaI fragment of pLG813 carrying the mutation into pPSG51 cut by BglII and HpaI. The authenticity of the in vitro recombinant was confirmed by DNA sequencing.
Denaturation-renaturation of HlyA activity. This was carried out as described previously (Pimenta et al., 2005) .
Standard haemolytic assay and activity of HlyA determined by the titration method. These were carried out as described previously (Pimenta et al., 2005) . In the titration method, one haemolytic unit was defined as the amount of HlyA necessary to produce 50 % lysis of the erythrocytes. All results are expressed as averages of duplicate samples unless otherwise stated and are given per ml of culture supernatant.
Measurement of b-lactamase activity in culture supernatants. This was performed as described by Chervaux et al. (1995) . Units of b-lactamase activity were proportional to the amount of fusion protein over at least a 20-fold range (0.05-1 mg).
Preparation of protein samples from cells and supernatants.
Cells were recovered from cultures by centrifugation at 12 000 g for 10 min and resuspended in SDS sample buffer. Protein-containing supernatants were obtained by two further successive centrifugations at 27 000 g each for 15 min and protein was precipitated by addition of TCA [final concentration 10 % (w/v)]. After 1 h on ice, proteins were pelleted by 30 min centrifugation at 16 000 g and resuspended in SDS sample buffer. Each sample was boiled for 10 min before loading on the gel.
Purification of wild-type and HlyAdel6. Pro-HlyA (lacking the internal acylation sites) and wild-type HlyA were purified from IBs. IBs were washed three times with buffer A (50 mM Tris/HCl, 1 mM DTT, 1 mM EDTA, 0.1 % NaN 3 , 0.5 % Triton X-100, pH 7.0) and once with buffer B (50 mM Tris/HCl, 1 mM DTT, 0.1 % NaN 3 , pH 7.0). After every washing step, the sample was centrifuged at 30 000 g, for 30 min at 4 uC. IBs were finally dissolved in 50 mM Tris/ HCl, 8 M urea, pH 7.0. Purification was achieved by anion-exchange chromatography (DEAE fast flow Sepharose, GE Healthcare) with 50 mM Tris/HCl, 8 M urea, 0-300 mM NaCl, pH 7.0 and size exclusion chromatography (SEC; 50 mM Tris/HCl, 8 M urea, pH 7.0). Subsequent cation-exchange chromatography (SP Sepharose; GE HEalthcare) and another SEC step resulted in proHlyA purified to homogeneity, which was suitable for fluorescence spectroscopy studies ( Supplementary Fig. S3 , available with the online version of this paper). During an early attempt to purify wild-type, acylated HlyA, we encountered problems with the hydrophobic molecule sticking to the anion exchange column resin. Furthermore, the purified protein showed a strong tendency to form high molecular mass aggregates. We considered that this problem might be due to the acylation of pro-HlyA. Therefore, we decided to purify proteins (wild-type HlyA and HlyAdel6) for tryptophan fluorescence measurements, following expression in a strain lacking hlyC that normally activates HlyA via acylation of the two lysine residues. This procedure enabled us to purify successfully the two proteins without visible contamination, which is important for the fluorescence spectroscopy ( Supplementary Fig. S3 ).
Trypsin treatment. E. coli NM522 carrying pPSG51 (wild-type or hlyA99 signal sequence) and pLG814 or pLG339 (as a vector control minus hlyBD) were grown at 37 uC in LB plus antibiotics as described above. blac-23kDaHlyA synthesis was induced by 0.5 M IPTG at OD 600 50.5 and growth was followed to OD 600 54. Supernatants were separated from cells by centrifugation at 4 uC (20 min at 3000 g in a Sorvall SA600 rotor). An aliquot (1 ml) of each supernatant was kept as a trypsin minus control; trypsin (bovine pancreatic, 100 mg ml 21 in 100 mM Tris/HCl, pH 8) was added to the remaining supernatant to a final concentration of 10 mg ml 21 . A 1 ml aliquot was immediately taken and mixed with 30 mg trypsin inhibitor ml 21 (Sigma). Samples were taken at intervals and proteins were precipitated by 10 % TCA; 0.2 OD 600 units were loaded for SDS-PAGE (12 % acrylamide), before transfer to nitrocellulose filters. Proteins were then revealed using anti-b-lactamase or anti-haemolysin antibodies.
For treatment of whole cells, bacteria (3 OD 600 units) were suspended in MgCl 2 (10 mM), Tris/HCl (10 mM, pH 7.2) plus 50 mg trypsin ml 21 and incubated at 4 uC for 30 min; digestion was stopped by PMSF (5 mM) and excess trypsin inhibitor. Under these conditions, trypsin does not penetrate to the periplasm (Halegoua & Inouye, 1979) .
Kinetic analysis of HlyA translocation. E. coli SE5000 (pLG814; pLG813 encoding either hlyA or hlyA99) was grown in M63 medium (1 mM CaCl 2 ) to OD 600 50.5; 7 ml samples were labelled with ). Samples (1 ml) were taken at different chase times and mixed with 0.9 ml ice-cold phosphate buffer (10 mM, pH 7.5, plus 50 mg BSA ml 21 as carrier, 3 mM sodium-azide and 50 mM CCCP). Samples were centrifuged twice to give cell-free supernatants; protein was precipitated with 10 % TCA (w/v) and precipitates were suspended in 20 ml sample buffer and analysed by SDS-PAGE (12 % acrylamide) and by fluorography.
Tryptophan fluorescence spectroscopy. Protein samples (wildtype, pro-HlyA and pro-HlyA Del6) were prepared by dilution from 50 mM Tris/HCl, 8 M urea (pH 7.0) into assay buffer containing 50 mM Tris/HCl, 20 mM Ca 2+ , 0.5-8 M urea (pH 7.0). Protein samples were incubated for between 24 and 120 h at 4 uC in assay buffer to reach equilibrium. Protein fluorescence was measured with a Fluorolog 3 instrument (HoribaJobinYvon) at 25 uC. Excitation wavelength was 295 nm and slits were set to 2 nm. Emission was recorded between 310 and 500 nm and slits were set to 5 nm. For subsequent analysis, the change in normalized fluorescence intensity at 329 nm was followed.
RESULTS

Isolation of the HlyA99 mutant and its initial characterization
An analysis of HlyA secretion using random hydroxylamine mutagenesis revealed a C-terminal mutation (hlyA99) corresponding to four substitutions (all GC to AT transitions as expected for hydroxylamine mutagenesis) in the last six residues of the protein. This resulted in a sequence change from -TLTASA to -ILIVSV (Fig. 1a ). This part of the normal signal sequence is particularly rich in hydroxylated amino acids and has been shown previously to be important but not essential for secretion (Holland et al., 2003) . Thus, deletion of the seven C-terminal residues was reported to allow secretion of HlyA protein to the medium of at least 30 % of wild-type levels (Koronakis et al., 1989) . However, no effect of such mutations on the activity of HlyA was examined. The hlyA99 mutant in fact has a phenotype of low haemolytic activity on blood agar plates at 37 u C, giving colonies with small haloes (data not shown). Moreover, in liquid LB medium at 37 u C, levels of haemolytic activity were detected in the culture supernatant at approximately 10 % of that of the wild-type (Fig. 1b ) (see also Table 1 ).
The hlyA99 mutant protein is secreted relatively efficiently but haemolytic activity is reduced
In order to measure any secretion defect associated with the hlyA99 mutation, the amount of HlyA protein in the supernatant of both mutant and wild-type cultures grown at 37 u C in LB medium was analysed by Western blotting with anti-HlyA antibodies (Fig. 1c) and by SDS-PAGE with Coomassie-blue staining (Fig. 1d) . Surprisingly, densitometric analysis (see Methods) indicated that the amount of protein secreted to the medium by the mutant was as high as 40-50 % of that obtained with wild-type haemolysin. Fig. 1(d) also indicates that the antibody detected some lower molecular mass bands in the culture supernatant; however, these are unlikely to be HlyA degradation products as they were also detected in the supernatant from cells not expressing HlyBD. The same relatively high level of secretion was obtained (data not shown) when the C-terminal 217 aa of HlyA (23 kDa) carrying the hlyA99 mutation were expressed from the lac promoter of the M13mp18 phage (see Methods). The combination of all these results indicated that the mutant toxin was primarily defective in haemolytic activity.
To completely eliminate the possibility of other upstream mutations in hlyA being responsible for these properties, a 39 fragment of the mutant hlyA99 gene, corresponding to the C-terminal 27 aa, was exchanged in vitro for the 39 end of an otherwise wild-type hlyA (see Methods). The reconstituted gene was then co-expressed in cells with hlyBD and again the secreted protein was found to have reduced activity. Thus, the level of secretion of the mutant protein was approximately 40 % of wild-type levels but the haemolytic activity corresponded to approximately 12 % of the wild-type level in the culture supernatant, giving an apparent reduction in specific activity of at least 2.5-fold (see Table 1 ).
The hlyA99 mutation is dominant in competition experiments with wild-type HlyA
We showed previously that co-expression of wild-type HlyA and a large fusion protein composed of virtually the whole b-galactosidase protein fused upstream of the Cterminal 81 kDa of HlyA (CIZ-HlyA), in cells also expressing hlyCBD (Kenny et al., 1994) , leads to inhibition of wild-type HlyA secretion. The CIZ-HlyA fusion protein itself (encoded by pLG811) is secreted to the medium but only at very low levels, while large amounts of the fusion protein accumulate in the cell envelope in an hlyBDdependent manner, presumably blocking the translocator. Importantly, we also showed that mutations located between residues 215 and 246 with respect to the HlyA C terminus that were introduced into the CIZ-HlyA signal sequence alleviated the inhibition of secretion of the coexpressed HlyA. These mutations could therefore be considered recessive.
In order to test the dominance or recessitivity of hlyA99 (substitution ILIVSV at the C terminus) in such a competition experiment, the HlyA99 mutation was introduced into the CIZ-HlyA secretion signal by in vitro recombination (see Methods). The CIZ-HlyA fusion itself has no haemolytic activity (data not shown), presumably because it lacks most of the N-terminal hydrophobic region of HlyA. Therefore, in competition experiments, only the haemolytic activity of the co-expressed wild-type HlyA was detected in the culture medium. In cells expressing the CIZ-HlyA fusion, together with hlyCBD and wild-type hlyA, the colony halo size on blood agar was small or undetectable but increased as expected when mutations that reduce secretion of HlyA were introduced into the fusion (data not shown). However, when the hlyA99 mutant secretion signal was introduced into the CIZ-HlyA molecule, no increase in halo size was observed. This result is in clear contrast with the recessive secretion signal mutations analysed previously, indicating that the HlyA mutation is dominant.
The competitive effect of CIZ-HlyA99 was then analysed in liquid culture by measuring the levels of haemolytic activity of co-expressed HlyA toxin released into the culture supernatant. Samples of supernatant and total cell proteins were taken at intervals from an exponentially growing culture and analysed for activity and by SDS-PAGE. Fig. 2(a) shows that on the basis of activity measurements, CIZ-HlyA99 inhibited the secretion of co-expressed HlyA as efficiently as a fusion carrying the wild-type signal. As expected, the presence of a non-sense mutation (D55), leading to the deletion of the 55 C-terminal amino acids of the CIZ-HlyA fusion, also alleviated this inhibition by CIZ-HlyA, which is in contrast with hlyA99. Moreover, another control, a point substitution at position 235 (Phe Table 2 . A blac-HlyA fusion carrying the HlyA secretion signal mutation hlyA99 has reduced specific activity b-Lactamase activity was calculated for culture supernatants containing the b-lac-23kDaHlyA fusion protein carrying the wild-type secretion signal or the hlyA99 mutant secretion signal, expressed from pLG813 and pPSG51, respectively. In order to compare apparent specific activities, the amount of secreted protein was determined by densitometry following SDS-PAGE analysis (see Fig. 5 ).
Protein sample b-Lactamase activity per OD 600 unit of culture supernatant (mmol min "1 OD 600
b-Lactamase specific activity in culture supernatant (% of wild-type blac-23kDaHlyA)
Wild-type blac-23kDaHlyA 0.227 100 hlyA99 mutant blac-23kDaHlyA 0.028 40 to Pro) which reduces secretion of HlyA when present in the CIZ-HlyA fusion (Chervaux & Holland, 1996) , also alleviated the inhibition of HlyA secretion, as measured by haemolytic activity.
Data shown in Fig. 2(b) confirm that CIZ-HlyA99 inhibited secretion of the co-expressed HlyA when immunoblotting was used to reveal the amount of each protein present in the culture supernatants. Thus, expression of CIZ-HlyA reduced the amount of HlyA protein found in the supernatant (Fig. 2b, lanes 1 and 5) . In contrast, as expected, when mutation F989P (position 235) or the non-sense mutation (D55) was present in CIZ-HlyA, the competitive effect was alleviated and significantly more HlyA protein was found in the supernatant (Fig. 2b, lanes 2 and 4) . However, with hlyA99 present in the CIZ-HlyA secretion signal, the amount of HlyA protein secreted and detected in the supernatant remained very low, while the amount of CIZHlyA itself present in the supernatants was reduced according to the particular secretion signal mutation introduced, as expected.
The data in Fig. 2 clearly show that when present in the CIZ-HlyA fusion, the hlyA99 mutation is dominant, since it specifically inhibited secretion of co-expressed wild-type HlyA. Consequently, whilst the previously analysed mutations appeared to affect an early step in translocation, probably the initial recognition step, this hlyA mutation ( Supplementary Fig. S2 ) must affect a later step in the transport pathway, resulting in a secreted protein with reduced activity.
Localization of cell-associated wild-type HlyA and HlyA99 probed by trypsin accessibility
Previous studies have indicated that production of hlyA mRNA is blocked when HlyA is not secreted, for example, in strains not expressing hlyBD (M. A. Blight and I. B. Holland, unpublished data). On the other hand, significant amounts of secreted HlyA remain associated with the cell envelope, accessible to extracellular trypsin, in strains expressing hlyBD (Pimenta et al., 2005) . When wild-type HlyA and HlyA99 were compared in the presence of HlyBD, high levels of the wild-type protein were found to be cell-associated, with apparently even higher levels detected in the case of the mutant HlyA99 protein (Fig. 3) . When cells were treated with trypsin, the HlyA99 protein, like wild-type HlyA, was completely degraded by addition of trypsin to cells (Fig. 3) under conditions where the protease does not penetrate the cell . Substantial amounts of wild-type HlyA and HlyA99 produced in the presence of hlyBD are secreted to the surface and are accessible to exogenous trypsin. Strain SE5000 expressing hlyBD (pLG814) and hlyA or hlyA99 (from pLG813) was grown in LB medium at 37 6C. Total cells were harvested at OD 600 56 and the supernatant, containing Hly secreted to the medium, was removed by centrifugation and washing. The cells, resuspended in 10 mM Tris/HCL plus 10 mM MgCl 2 (see Methods), were either left untreated or treated with trypsin (50 mg ml "1 ) as described in Methods. Total cell protein of cells of each strain (OD 600 equivalents) was then analysed by SDS-PAGE, followed by Western blotting against anti-HlyA antibody.
envelope (Halegoua & Inouye, 1979) . In both wild-type and mutant, therefore, all cell-associated HlyA molecules have been secreted to the surface, are accessible to trypsin and apparently neither wild-type nor mutant HlyA accumulates in the cytosplasm. The control experiments ( Supplementary Fig. S3 ) demonstrated that trypsin treatment has no detectable effect on total protein profiles from treated cells nor the low levels of cytoplasmic HlyA present in cells lacking HlyBD, indicating that trypsin does not penetrate into cells under these conditions. The results shown in Fig. 3 also suggest that the true secretion levels of HlyA99 were underestimated, with relatively more protein accumulating at the cell surface. Thus, these results indicated that the secretion of the HlyA99 mutant was relatively unimpaired. However, no conclusions about the kinetics of translocation can be drawn from these experiments.
Kinetics of translocation of wild-type HlyA and HlyA99
In order to compare the kinetics of translocation of wildtype HlyA and HlyA99 to the medium, cells expressing hlyBD and either mutant or wild-type hlyA were grown in M63 minimal medium at 37 u C, pulse-labelled with [ 35 S]methionine and chased with cold methionine (see Methods). As shown in Fig. 4 , HlyA99 was secreted to the medium at levels about 40 % of that of the wild-type toxin, but the time-course of secretion was similar to that of the wild-type HlyA. In summary, these results indicated that the translocation of HlyA99 was not defective per se, although its ability to fold and leave the cell surface may be perturbed.
The hlyA99 mutation also affects the specific activity of b-lactamase in the chimeric blac-
23kDaHlyA protein
The HlyA99 mutation markedly affected the haemolytic activity of HlyA (Table 1) . This is particularly evident in the case of HlyA Del6, where the mutation has relatively little effect on the levels of HlyA toxin secreted to the medium (see below). However, it has been generally assumed that the haemolytic domain of HlyA is delimited by the presence of the glycine-rich repeats located between residues 730 and 840. Consequently, it was surprising that mutations at the extreme C terminus of HlyA, within the approximately 50 residues thought to constitute the secretion signal, appeared to influence the activity of haemolysin molecules. We therefore considered the possibility that the secretion signal region has an additional function and that the effect of the mutations might indicate that the C-terminal region also plays an important role in the correct folding of HlyA molecules.
In an attempt to test the idea that the C terminus may be involved in folding of the protein, we analysed the effect of the hlyA99 mutation on secretion and activity of a chimeric protein composed of E. coli TEM b-lactamase and a Cterminal part (23 kDa) of HlyA, which lacks the majority of the RTX repeats and the large N-terminal toxin domain. This fusion protein is only secreted in the presence of the translocator proteins HlyBD. Moreover, the secreted form of this fusion appeared to have the same specific activity as normal b-lactamase (Holland et al., 2003) . We introduced the cluster of four substitutions constituting the hlyA99 mutation into the signal sequence of the b-lactamaseHlyA23 kDa fusion (blac-23kDaHlyA) (see Methods). Secretion of the chimeric proteins, carrying either the wild-type or the mutant secretion signal, was followed by both measurement of b-lactamase activity in the medium and quantification of the amount of the corresponding protein in culture supernatants. Typical results are shown in Fig. 5a , b, where Coomassie-blue-stained and Western blot analyses of supernatant proteins are shown. In these experiments, cultures were grown to late exponential phase for maximum secretion levels. The amount of blac23kDaHlyA99 detected was usually between 30 and 50 % compared with the hybrid protein carrying a wild-type secretion signal. Both staining and immunodetection gave similar results. This level of secretion was close to the level of secretion of the HlyA toxin itself carrying the same mutation (see Fig. 1c, d ).
However, when the b-lactamase activity in culture supernatants was measured, an eightfold reduction in activity levels of the chimeric protein carrying the hlyA99 mutation, relative to the wild-type, was obtained, equivalent to a reduction in specific activity of 2.5-fold (40 %) ( Table 2) . When the stability of blac-23kDaHlyA99, following secretion to the medium, was measured by its penicillinase activity, this remained essentially identical over 2 h to that of the fusion with a wild-type secretion signal (data not Fig. 4 . Kinetics of translocation of wild-type HlyA (#) and HlyA99 ($). Strain SE5000 (pLG813, pLG814) was grown at 37 6C in M63 (+1 mM CaCl 2 ) to OD 600 50.5 and pulse-labelled with [ 35 S]methionine for 30 s and chased in cold medium; samples were analysed by SDS-PAGE and fluorography. X-ray films were scanned to quantify gel bands in arbitrary units (AU). SE5000 (pLG813) carried either wild-type hlyA or hlyA99.
shown). These results therefore demonstrated that the hlyA99 mutation has a similar debilitating effect on the specific activity of the attached b-lactamase as that found for the HlyA toxin itself. This result also clearly indicated that the hlyA99 mutation does not simply affect the haemolytic activity per se, i.e. because the C terminus is directly required for toxin activity. Rather, this suggested that the mutation affects the correct folding of proteins in some way, for example, with the C terminus of HlyA normally acting as a folding nucleation centre as the polypeptide emerges from the HlyBD-TolC translocator.
Deletion of the six C-terminal residues mimics the effect of the hlyA99 mutation To examine further the role of the amino acids at the extreme C terminus of HlyA, we simply deleted the six Cterminal residues to generate HlyA Del6. The properties of this mutant were very similar to those of the hlyA99 mutation. Removal of the six C-terminal residues had a modest effect on the level of secretion of the HlyA protein to the medium; this was approximately 70 % of the wildtype level (Table 1) . However, as found with hlyA99, a major effect of the deletion of the C-terminal six residues was on the haemolytic activity in the culture medium, with a reduction in the apparent specific activity of close to threefold. Therefore, with both mutants, hlyA99 and hlyAdel6, the results indicated that the extreme C terminus was in some way essential for activity.
The hlyA99 and hlyAdel6 mutations inhibit renaturation of HlyA to the haemolytic form following denaturation in vitro Haemolysin inactivated in vitro by denaturation with urea or guanidine chloride (GnCl) can be renatured and therefore reactivated to the haemolytic form by rapid dilution. Moreover, we have shown that HlyA molecules with reduced activity due to mutations in HlyD can be restored to full activity following denaturation and then renaturation (Pimenta et al., 2005) . Wild-type haemolysin, HlyA99 and HlyA Del6 in culture supernatants were therefore concentrated by precipitation by ammonium sulphate, denatured by resuspending in 6 M GnCl and renatured by dilution into assay buffer (see Methods) to measure haemolytic activity.
Wild-type haemolysin regained slightly greater than 100 % activity after renaturation (Table 1) , a result not unexpected due to the tendency of even wild-type HlyA to aggregate and lose activity in the growth medium (Goni & Ostolaza, 1998) . Both mutant proteins (HlyA99 and HlyA Del6) showed a slight increase in activity after renaturation; however, their calculated specific activities remained at only 40 % relative to the wild-type protein. Therefore, in vitro these mutant proteins appear to display essentially the same reduced ability to refold to the active form as observed when they are initially secreted to the medium. This result rules out the possibility that initial misfolding is simply a consequence of perturbations Fig. 5 . Analysis of the secretion efficiency of the blac-23kDaHlyA fusion protein (encoded by pPSG51) carrying the hlyA99 mutation. (a) Coomassie-blue-stained gel. Lanes 1 to 4, different OD 600 equivalents of samples containing the secreted blac-23kDaHlyA with a wildtype secretion signal; lane 5, 1 OD 600 equivalent of supernatant from a culture expressing blac-23kDaHlyA99; lane 6, 1 OD 600 supernatant equivalent from a culture expressing wildtype blac-23kDaHlyA in a strain lacking hlyBD. (b) Western blot analysis of the same supernatant samples as in (a), using anti-HlyA antibody. The OD 600 loading equivalents are indicated. (c) Measurement of supernatant levels of secretion of blac-23kDaHlyA, wildtype secretion signal or hlyA99. As in (a) and (b), supernatants from NM522 cultures expressing HlyBD and blac-23kDaHlyA wild-type secretion signal or hlyA99 were analysed by SDS-PAGE and Coomassie-blue staining. In order to compare the amounts of secreted proteins in each culture supernatant, serial dilutions were loaded on the same gel. OD 600 equivalents of wild-type culture supernatant are indicated. The position of the blac-23kDaHlyA protein is indicated.
occurring during translocation onto the surface or prior to final release into the medium.
Protein folding of wild-type pro-HlyA and pro-HlyA Del6 monitored by fluorescence spectroscopy
To validate further our data that the extreme C terminus of HlyA plays a specific role in protein folding, we chose fluorescence spectroscopy to detect structural changes within the protein. For technical reasons, we used the pro-form of HlyA (see Methods), which, without acylation, is not able to lyse red blood cells (Holland et al., 2003) . Nevertheless, the non-acylated pro-HlyA was shown previously to bind and insert into liposome membranes as efficiently as the acylated form (Hyland et al., 2001) . Together, these results indicated that pro-HlyA and acylated HlyA molecules fold similarly. Thus, in light of the technical problems encountered during the purification of HlyA, we chose pro-HlyA as a suitable model protein to follow up our initial hypothesis that the C terminus of HlyA may provide a folding as well as a targeting function (see Supplementary Fig. S4 ).
When we compared the normalized tryptophan fluorescence of both the wild-type pro-HlyA and pro-HlyA Del6 proteins at high concentrations of urea (2-8 M), the results obtained were very similar (Fig. 6) . In both cases, the observed constant decrease in fluorescence paralleling the increase in urea can be assigned to the unfolding of the HlyA protein. In support of this conclusion, lysis of red blood cells by HlyA treated with .3 M urea resulted in the complete loss of lytic activity (data not shown). In contrast with the above results, at low concentrations of urea (in the range of 0.5-1 M) the wild-type protein and the HlyA mutant lacking the six C-terminal amino acid residues differed with respect to the effect on tryptophan fluorescence and therefore the structure of the pro-HlyA molecule. Thus, under these conditions the mutant protein appeared relatively more compact and more resistant to the significant conformational changes undergone by the wildtype protein. We therefore concluded that the fluorescence spectroscopy data support the hypothesis that the extreme C terminus of the HlyA molecule influences the structure/ folding properties of HlyA and nicely complement our whole cell experiments that initially led us to the assumption of a dual role for the C terminus of HlyA.
DISCUSSION
Secretion of proteins carrying a C-terminal secretion signal via the type I pathway are, in all probability, translocated in an unfolded form across the cell envelope (see Discussion in the paper by Pimenta et al., 2005) . Consistent with this idea, different lines of evidence indicate that type I polypeptides do actually undergo some folding on the cell surface. First, previous studies have implicated lipopolysaccharide as a requirement for formation of haemolytically active HlyA (Bauer & Welch, 1997) . Second, mutations in either TolC (Vakharia et al., 2001) or HlyD (Pimenta et al., 2005) also result in secreted HlyA with reduced haemolytic activity. This seems likely to result from perturbed translocation through the translocator, conceivably leading to uncoordinated misfolding as the protein emerges on the surface, since in vitro denaturation and renaturation of HlyA secreted from these mutants largely restored haemolytic activity and therefore normal folding. Strikingly, such a restoration or rescue of the normal folding pathway was not obtained with the HlyA mutants studied here. Finally, an important contributor to folding of HlyA on the surface is most likely the binding of calcium ions to the RTX repeats, as first suggested by Baumann et al. (1993) based on the crystal structure of the type I protein alkaline protease from Pseudomonas aeruginosa. In reality, the extremely low levels of free Ca 2+ present in the E. coli cytoplasm (less than 1 mM), which is equivalent to around 100 ions (Jones et al., 2002) , most probably precludes or severely limits any folding in the cytoplasm based on this mechanism.
Residues close to the C terminus of HlyA were previously shown to be important for secretion of the toxin to the medium, since progressive deletion of from between 7 and 27 residues from the C terminus resulted in secretion of HlyA to the medium at levels of between 30 % and less than 0.5 %, respectively, compared with the wild-type toxin (see Holland et al., 2003) . The hlyA99 mutation involves four substitutions in the last six C-terminal residues, including the terminal Ala to Val (see Fig. 1a) , with the most significant changes probably being substitutions of small Fig. 6 . Protein fluorescence spectroscopy of wild-type pro-HlyA (#) and pro-HlyA Del6 ($). Protein samples were purified to homogeneity and prepared and analysed as described in Methods. A characteristic change in fluorescence emission was observed at 329 nm and normalized fluorescence was plotted against urea concentration. For low urea concentrations (0.5-1 M) a significant difference in protein fluorescence was detected, which can be assigned to a difference in protein structure. Values given are averages of three independent experiments and different equilibration times (24-120 h).
hydroxylated Thr residues (positions 24 and 26) for larger Ile residues. In unpublished studies, we showed that the terminal Ala could be replaced by Pro or Gln without any detectable effect on secretion. However, compatible with some specific function, the immediate upstream region is relatively well conserved (L-Hx-Hx-Hx-A, where Hx is hydroxylated or Ala) in HlyA-like RTX toxins. Importantly, previous studies showed that type I signal sequence mutations, which mostly reduce secretion levels to well below 50 % and map to positions 215 to 246 with respect to the C terminus, were recessive, i.e. they alleviated competitive inhibition of secretion of wild-type HlyA by the co-expressed CIZ-HlyA fusion. Thus, such mutations apparently affected an early step in secretion of HlyA, probably recognition of the translocator (Holland et al., 2003) . In contrast, the hlyA99 mutation, when present in CIZ-HlyA, was shown to be dominant in competition experiments, indicating that the mutation primarily affects a later step which is after initiation of translocation of HlyA (Fig. 2) .
The amount of HlyA99 protein detected as being secreted to the medium was reduced compared with the wild-type, with final levels varying from 30 to 50 % in different experiments. However, as we show in this study (see also Pimenta et al., 2005) , we note that secretion efficiency can be routinely underestimated, since significant amounts of wild-type HlyA are translocated to the outer cell surface but are not released. This is in line with recent findings that in addition to direct extrusion to the medium, HlyA can subsequently be released from the surface in the form of outer membrane vesicles (Balsalobre et al., 2006) . Interestingly, even larger amounts were apparently found on the surface with the HlyA99 mutant compared with the wild-type (Fig. 5a) , consistent with the altered folding of the mutant protein.
Further evidence that translocation is modestly affected by the HlyA99 mutation was shown by pulse-chase experiments which showed that the time-course for translocation of the mutant is similar to that of wild-type HlyA. Importantly, the hlyAdel6 deletion mutation, which like hlyA99 has a major effect on the activity of HlyA, showed only a minimal secretion defect with close to 70 % of wildtype levels in the medium. We conclude, therefore, that the effect of these C-terminal mutations is primarily to reduce the activity of secreted molecules rather than their translocation efficiency.
Three possible explanations for the reduced haemolytic activity of the HlyA mutants can be envisaged: (i) if the extreme C terminus of HlyA is specifically required for modification by HlyC; (ii) if the extreme C terminus is directly implicated in lysis of erythrocytes; or (iii) if the C terminus has a specific role in refolding of secreted molecules. A previous study (Stanley et al., 1994) has shown that the two specific sites for HlyC-dependent acylation are located 288 and 414 residues, respectively, upstream of the C-terminal secretion signal. Involvement of the C terminus in the acylation reaction seems extremely unlikely, since HlyA lacking the N-terminal part containing the proposed amphipathic helices, or deletion of the Cterminal part, which contains the secretion signal, were still acylated normally in vitro (Stanley et al., 1994) . Despite many detailed genetic and biochemical studies of the properties of HlyA and its interaction with membranes, no evidence has been presented in the literature to indicate that the C terminus of HlyA is directly involved in haemolytic activity. In contrast, we suggest that several findings in this study point to a role for the extreme C terminus in protein folding. Thus, the cis-dominant effect of the hlyA99 mutation on the activity of b-lactamase fused to the C terminus of HlyA is most easily explained in this way. Moreover, the HlyA mutant proteins analysed in this study were essentially refractory to reactivation following denaturation in urea, consistent with inherently defective molecules, which cannot refold correctly in vitro. This is in complete contrast with the successful restoration of activity to inactive HlyA secreted from HlyD or TolC mutants (Pimenta et al., 2005; Vakharia et al., 2001) . This result, combined with the relatively normal kinetics of translocation of HlyA99, appears to rule out effects on folding of these HlyA mutants incurred through perturbed movement through the translocator. Importantly, tryptophan fluorescence spectroscopy studies to monitor protein folding in the presence of urea clearly revealed significant differences between the wild-type proHlyA and pro-HlyA Del6 mutants at low urea concentrations (Fig. 6) . The wild-type protein in fact appeared more susceptible to structural changes under these conditions, suggesting that the mutant may have a relatively more stable or compact conformation; this may be less compatible with insertion of the HlyA molecule into membranes. The reduced activity of the deletion mutant may be particularly instructive since this implies a positive, active role in the normal refolding for the C terminus rather than a disruptive effect on folding created by the multiple mutations in HlyA99. The results of this experiment nevertheless point towards a crucial involvement of the extreme C terminus of HlyA in the folding of the toxin, acting in concert with other folding mechanisms, as the polypeptide emerges on the cell surface from the translocator.
Interestingly, Chenal et al. (2009) and Sotomayor Perez et al. (2010) recently showed that milimolar concentrations of Ca 2+ ions in vitro promote the compaction of the normally disordered RTX region of a type I protein, together with increased formation of stable secondary and tertiary structures. This is consistent with the findings of Pimenta et al. (2005) who showed that the amount of HlyA secreted and the activity of HlyA increased in line with the extracellular Ca 2+ concentration over a millimolar range. Chenal et al. (2009) indeed proposed that Ca 2+ -dependent folding of the RTX region of emerging HlyA proteins could contribute a nucleus for folding of the more proximal regions of the protein. Intriguingly, the geometry of the HlyA molecule -with conceivably at least two distinct types of folding pathway triggers, positioned towards the C terminus of the protein -the RTX Ca 2+ repeats and the Cterminal end itself, suggest that the C terminus may lead the way out of the translocator. Finally, we conclude that the role of the 50-60 amino acid HlyA secretion signal region may not only be limited to targetting HlyA to the translocator but also be involved in promoting the correct folding of the toxin.
